C07D 233/38
With acyl radicals or hetero atoms directly attached to ring nitrogen atoms
Official title: with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
C07D233/38 (With acyl radicals or hetero atoms directly attached to ring nitrogen atoms) appears on 138 US grants and 83 published applications in this corpus.
Search patents in C07D- Granted patents
- 138
- Published applications
- 83
- Assignees
- 87
- Inventors
- 402
- Latest grant
- 5 Mar 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 11 | 0 |
| 1977 | 1 | 0 |
| 1978 | 4 | 0 |
| 1979 | 6 | 0 |
| 1980 | 6 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 5 | 0 |
| 1984 | 2 | 0 |
| 1985 | 3 | 0 |
| 1986 | 5 | 0 |
| 1987 | 4 | 0 |
| 1988 | 3 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 0 | 0 |
| 1993 | 4 | 0 |
| 1994 | 1 | 0 |
| 1995 | 5 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 1 |
| 2002 | 10 | 12 |
| 2003 | 1 | 4 |
| 2004 | 1 | 7 |
| 2005 | 2 | 9 |
| 2006 | 3 | 4 |
| 2007 | 0 | 1 |
| 2008 | 3 | 3 |
| 2009 | 5 | 5 |
| 2010 | 3 | 3 |
| 2011 | 1 | 3 |
| 2012 | 1 | 0 |
| 2013 | 3 | 1 |
| 2014 | 1 | 2 |
| 2015 | 0 | 2 |
| 2016 | 2 | 4 |
| 2017 | 2 | 2 |
| 2018 | 1 | 4 |
| 2019 | 2 | 2 |
| 2020 | 2 | 6 |
| 2021 | 3 | 1 |
| 2022 | 3 | 2 |
| 2023 | 2 | 2 |
| 2024 | 1 | 2 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Alpha-cinnamide compounds and compositions as HDAC8 inhibitors5 Mar 2024US 11,919,839 B2Valo Health, Inc.
- Non-fused thiophene derivatives and their uses12 Dec 2023US 11,840,527 B2Enyo Pharma
- Non-fused thiophene derivatives and their uses26 Sep 2023US 11,767,316 B2Enyo Pharma
- Antibacterial hydrophilic compound and use thereof22 Nov 2022US 11,503,828 B2Shenzhen University
- Necrosis inhibitors25 Oct 2022US 11,478,438 B2National Institute of Biological Sciences, Beijing
- Small molecule inhibitors of pr3 and hne and uses thereof13 Feb 2025US 2025/0051286 A1Orixa Therapeutics LLC
- Nonaqueous electrolytic solution, nonaqueous electrolytic solution battery, and compound25 Apr 2024US 2024/0136578 A1Central Glass Company, Limited
- Protein and lipid therapeutic targets4 Jan 2024US 2024/0002350 A1National Center for Advancing Translational Sciences/Dpi/Nih
- Intermediate, preparing method thereof, and method of preparing drug27 Jul 2023US 2023/0234973 A1Heron Neutron Medical Corp.
- Antibacterial hydrophilic compound20 Apr 2023US 2023/0119640 A1Shenzhen University
Most cited
By later US patents
- Spatially-addressable immobilization of anti-ligands on surfaces486US 5,252,743 AAffymax Technologies N.V. · 1993
- Spatially-addressable immobilization of anti-ligands on surfaces283US 5,451,683 AAffymax Technologies N.V. · 1995
- Spatially-addressable immobilization of anti-ligands on surfaces211US 5,482,867 AAffymax Technologies N.V. · 1996
- Efficient ligand-mediated Ullmann coupling of anilines and azoles85US 6,541,639 B2Bristol-Myers Squibb Pharma Company · 2003
- Anorexigenic 4-[(3,4-dialkoxyphenyl)alkyl]-2-imidazolidinone derivatives42US 4,308,278 AGyogyszerkutato Intezet · 1981